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Abstract
Background: The efficacy of adult stem cells is known to be compromised as a function of age. This therefore
raises questions about the effectiveness of autologous cell therapy in elderly patients.
Results: We demonstrated that the expression profile of stemness markers was altered in BM-MSCs derived from
old rats. BM-MSCs from young rats (4 months) expressed Oct-4, Sox-2 and NANOG, but we failed to detect Sox-2
and NANOG in BM-MSCs from older animals (15 months). Chondrogenic, osteogenic and adipogenic potential is
compromised in old BM-MSCs. Stimulation with a cocktail mixture of bone morphogenetic protein (BMP-2),
fibroblast growth factor (FGF-2) and insulin-like growth factor (IGF-1) induced cardiomyogenesis in young BM-MSCs
but not old BM-MSCs. Significant differences in the expression of gap junction protein connexin-43 were observed
between young and old BM-MSCs. Young and old BM-MSCs fused with neonatal ventricular cardiomyocytes in co-
culture and expressed key cardiac transcription factors and structural proteins. Cells from old animals expressed
significantly lower levels of VEGF, IGF, EGF, and G-CSF. Significantly higher levels of DNA double strand break
marker g-H2AX and diminished levels of telomerase activity were observed in old BM-MSCs.
Conclusion: The results suggest age related differences in the differentiation capacity of BM-MSCs. These changes
may affect the efficacy of BM-MSCs for use in stem cell therapy.
Background
Age-related changes in adult stem cells contribute to the
decline in tissue regenerative capacity [1,2]. Adult stem
cells are the primary driving force for tissue, and hence
organ specific self-renewal. The observed reduction in
tissue regenerative capacity suggests diminished stem
cell numbers in addition to compromised differentiation
and specific lineage commitment ability [2,3]. In rats
and mice, aging compromises the efficacy of MSCs
geared towards regeneration of damaged myocardial tis-
sue [4,5]. The aging micro-environment has also been
shown to pose an inhibitory effect on adult stem cell
mediated regeneration [3,6]. Genes involved in stemness,
genomic integrity and regulation of transcription are
age-repressed in MSCs undergoing replicative senes-
cence in vitro [7,8]. In this study, MSCs derived from
the bone marrow of 4 month old rats (young) were
compared to those derived from 15 month old rats
(old).
Results
Characterization of young and old BM-MSCs and
assessment of changes in pluripotent marker expression
The yield of MSCs from the bone marrow of all four
individual old rats was lower than that of young rats.
We observed higher numbers of plastic adherent colo-
nies in all four individual young rat cultures 24 hours
after initial seeding of equal volumes (15 mL) of bone
marrow aspirates from each individual animal. Young
rat cultures expanded rapidly, and reached over 80%
confluence before day 5 post primary isolation. In com-
parison, adherent colonies only became apparent in all
four old rat cultures after 6 days post primary isolation
(Additional file 1). Young BM-MSCs displayed elongated
fibroblast-like spindle shaped morphology (Additional
file 1). Old BM-MSCs displayed a spread out, flat
enlarged morphology (Additional file 1) with nuclei that
appeared larger in size. Using a Cedex HiRes non-flow
imaging cytometer, we observed larger average cell dia-
meter in trypsinized old BM-MSC cultures (Additional
file 1). All young and old BM-MSC cultures were nega-
tive for CD45 and CD31, and positive for CD105, CD90
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there might be age-related differences in the expression
profile of Oct-4, Sox-2 and NANOG in BM-MSCs
derived from young and old bone marrow. While old
BM-MSCs expressed Oct-4, the fluorescence signal
intensity was significantly lower in comparison to that
observed in young MSC cultures (Figure 1B). The
immunocytochemical observations were corroborated by
qPCR; we failed to detect Sox-2 and NANOG in old
BM-MSCs but all three markers were detected in young
BM-MSCs by qPCR (Figure 1C).
Multilineage differentiation capacity is diminished in BM-
MSCs from old rats
We assessed the plasticity of young and old BM-MSCs
by inducing differentiation into fat forming adipocytes,
bone forming osteocytes, cartilage forming chondrocytes
and cardiomyogenic cells. We observed the
accumulation of triglycerides in the cytoplasm of young
BM-MSCs after 48 hours of exposure to adipogenic dif-
ferentiation media. Young BM-MSCs progressively
changed morphology, and the size and number of lipid
vacuoles formed increased over 8 days of differentiation.
Transformation peaked at 8 days of differentiation, after
which all young BM-MSCs in each culture plate became
fully formed adipocytes and detached from the culture
surface into suspension (Figure 2A). The resulting adi-
pocytes stained positive for oil red-O and the adipocyte
lipid-binding protein FABP4 (Figure 2B). Old BM-MSC
cultures changed morphology but failed to differentiate
over 21 days of induction in adipogenic, osteogenic and
chondrogenic differentiation media (Figure 2A). We did
not detect FABP4 in old BM-MSC cultures and oil red-
O staining was negative (Figure 2B). We also observed
the production of a mineralized matrix and the forma-
tion of bone nodules in vitro in young BM-MSC
Figure 1 Assessment of pluripotent marker expression and characterization of young and old BM-MSCs: (A) Passage 3 BM-MSCs from
young and old rats were harvested and labeled with a PE-coupled antibody against CD45 and CD31, and FITC-coupled antibodies against
CD105, CD90 and CD73 or immunoglobin isotype control IgGs and analyzed with FACS. Histograms show counts for specific antibody staining
profiles (blue). (B) Immunocytochemical analysis demonstrates that old BM-MSCs express the pluripotent maker Oct-4 but fail to express Sox-2
and NANOG. (C) qPCR analysis for the relative expression of Oct-4, Sox-2 and NANOG in young and old BM-MSCs. We failed to detect Sox-2 and
NANOG in old BM-MSCs. Columns show the combined mean ΔΔCq values of young (n = 4) and old rats (n = 4) for each marker. Data represent
relative expression of transcripts normalized relative to GAPDH and expressed as the Mean ± SEM for three biologically independent
experiments (n = 3). The ‘‡’ sign indicates a significant difference between the indicated group and any passage 3 groups from younger donors
(p< 0.05). (n.d ~ not detectable)
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entiation media. Osteogenic differentiation of young
MSC cultures peaked at day 8 with a complete change
in cell morphology and gradual detachment of bone
nodules into suspension (Figure 2A). Young MSC cul-
tures stained positive for anti-osteocalcin and alizarin-
red (Figure 2B). After 8 days of exposure to chondro-
genic differentiation media, we observed the formation
of proteoglycan-rich soft collagen matrix in young BM-
MSC cultures (Figure 2A). Transformation peaked at
day 8 with a complete change in BM-MSC morphology
and detachment of fully formed chondrocytes into sus-
pension (Figure 2A). The differentiated chondrogenic
cells also stained positive for anti-aggrecan (Figure 2B).
Fluorescence signal intensity as detected by immunocy-
tochemistry was significantly higher in young BM-MSC
cultures (Additional file 2).
To further assess self-renewal and differentiation capa-
city in young and old BM-MSCs, we induced cardio-
myogenesis with a cocktail mixture of bone
morphogenetic protein (BMP-2), fibroblast growth fac-
tor (FGF-2) and insulin-likeg r o w t hf a c t o r( I G F - 1 ) .O l d
BM-MSCs progressively changed morphology and in
some cultures, we observed cell death in response to
cardiomyogenic differentiation media (Figure 3). Young
BM-MSC cultures first proliferated to become over con-
fluent and progressively changed morphology. We
observed progressive enlargement and elongation in
young BM-MSC cultures with the formation of ball and
stick-like morphology (Figure 3). By day 10 of induction,
the differentiating BM-MSCs formed a long cytoplasmic
process with a vacuolated appearance (Figure 3) similar
to that observed in adipogenesis but with uniquely dif-
ferent surface and morphological characteristics [9,10].
We did not observe contracting cells typical of NVCM.
However, differentiating cells connected to adjoining
cells, and formed myotube-like structures and string-
bead like formations (Figure 3). Immunostaining of dif-
ferentiated cells for GATA 4, Nkx2.5, cTnI, cTnT, cTnC
and myosin heavy chain was strongly positive and
revealed bi-nucleation (Figure 3 and Additional file 2).
Induced old BM-MSCs failed to express the same set of
cardiac markers (Figure 3 and Additional file 2). The
immunocytochemical observations were corroborated by
qPCR; we failed to detect significant levels of Nkx2.5,
GATA 4, cTnI, cTnT, cTnC and cTropomoysin tran-
scripts in old BM-MSCs (Additional file 3A).
Young and old rat BM-MSCs form gap junctions and
undergo cardiomyogenesis in co-culture with NVCM
The presence of cardiac connexins which form the basis
for cell-to-cell communication has been shown in
human and rat MSCs and between MSCs and cardio-
myocytes [11,12]. We hypothesized here that there
might be age-related differences in the expression of the
gap junction protein connexin-43 in MSCs alone and in
co-culture with ventricular cardiomyocytes. We
observed the typical punctate staining pattern of con-
nexin-43 in both young and old BM-MSC cultures and
in NVCM (Figure 4). Fluorescence intensity of con-
nexin-43 staining as detected by immunocytochemistry
was significantly higher in young BM-MSC cultures
Figure 2 In vitro differentiation capacity of young and old BM-MSCs: (A) Representative micrographs from each experimental group
showing morphological change after 21 days of differentiation. (B) Results of adipogenic, osteogenic and chondrogenic differentiation.
Representative micrographs showing anti-FABP4, Oil Red O, anti-osteocalcin, Alizarin Red-S and anti-aggrecan staining in cultured BM-MSCs from
each experimental group.
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NVCM, young and old BM-MSCs coupled and fused
with adjacent NVCM colonies. Fused young and old
BM-MSCs expressed GATA 4, Nkx2.5, Connexin-43,
cTnI, cTnT and myosin heavy chain, but failed to
express a-sarcomeric actinin in co-culture with NVCM
(Figure 5).
Assessment of DNA damage and telomerase activity in
young and old BM-MSCs
The phosphorylated histone H2A variant, g-H2AX is a
sensitive indicator of DNA damage [13-16]. We postu-
lated that MSCs derived from the bone marrow of old
rats will express higher levels of g-H2AX while display-
ing diminished levels of telomerase activity. We detected
significantly higher levels of g-H2AX, in old BM-MSC
cultures (Figure 6A). We failed to detect expression of
g-H2AX in young BM-MSC cultures (Figure 6A).
Furthermore, telomerase activity (Figure 6B) and popu-
lation growth (Figure 6C) was significantly higher in
young BM-MSC cultures. Transplanted MSCs have
been shown to provide a major beneficial effect through
paracrine signaling [17-20]; similar effects are to be
expected when young and old BM-MSCs are trans-
planted. We therefore tested the hypothesis that young
and old BM-MSCs might differentially express and
secrete growth factors and cytokines. Old BM-MSCs
expressed significantly lower levels of VEGF, EGF, IGF
and G-CSF transcripts (Additional file 3B).
Discussion
We demonstrated here using a rodent model that there
were differences in BM-MSCs associated with the age of
the animal from which the cells were isolated. We
observed rapid expansion in young BM-MSC cultures
and striking age-related differences in cell morphology,
population size and proliferation. Young BM-MSCs dis-
played elongated fibroblast-like spindle shaped morphol-
ogy. Old BM-MSCs displayed spread out, flat enlarged
morphology which is consistent with late passage and
extensively cultured BM-MSCs [7,21-23]. Consistent
with age-related decreased proliferation, we observed
diminished telomerase activity and significantly higher
levels of the DNA double strand break marker g-H2AX
in old BM-MSCs. Human fetal bone marrow is known
to contain approximately 1 in 10, 000 MSCs in
Figure 3 Assessment of cardiac specific lineage commitment potential in young and old BM-MSCs by Immunocytochemistry: Results
of cardiomyogenic differentiation after 21 days. Representative micrographs showing anti-GATA 4, Nkx2.5, cTnI, cTnT, cTnC and MHC
staining in cultured BM-MSCs from each experimental group.
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with our observations here, studies in rats, mice, and
rhesus macaque monkeys indicate that there is a corre-
lation between age and declining numbers of BM-MSC
[25-27].
There is conflicting data with regard to the effect of
aging on the bone forming ability of BM-MSCs
[21,26,28,29]. A few studies find no effect, but the
majority find age-related decline in differentiation
potential [30]. In this study, old BM-MSCs failed to dif-
ferentiate into osteocytes, chondrocytes and adipocytes.
We assessed cardiomyogenic potential by stimulation
with a cocktail mixture of BMP-2, FGF-2 and IGF-1, in
co-culture with NVCM and with conditioned media
derived from the co-culture system. Old BM-MSCs
failed to commit to the cardiac lineage when induced
with the cocktail mixture and conditioned media. We
observed expression of the cardiac phenotype in both
young and old BM-MSCs in co-culture with NVCM.
When injected into infarcted myocardium, old rat BM-
MSCs displayed scant myogenic transdifferentiation and
failed to adopt host myocardial tissue architecture in
Figure 4 Immunocytochemical analysis of Connexin-43 staining: Representative images of anti-connexin-43 staining in cultured BM-
MSCs from each experimental group. Columns show fluorescence signal intensity based on three independent differentiation experiments (n
= 3) per animal. The ‘‡’ sign indicates a significant difference between the indicated group and any passage 3 groups from younger donors (p
<0.05). Error bars designate means ± SEM.
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to co-culture is the fact that fusion of the two different
cell types can be misinterpreted as transdifferentiation
[31]. Expression of the cardiac phenotype in old BM-
MSCs under co-culture conditions in this present study
maybe explained in part by cell fusion.
We did not detect striations typical of NVCM in
young and old BM-MSCs as evidenced by the lack of
a-sarcomeric actinin staining in either cell type.
Furthermore, a significant number of GFP positive
cells in old BM-MSC cultures failed to express the car-
diac proteins analyzed in this study. Positive staining
for cardiac proteins was observed in regions of the co-
culture system where GFP positive BM-MSCs had
fused with NVCM. It is not clear that old BM-MSCs
acquired a broader differentiation potential in co-cul-
ture with NVCM that enabled commitment to the car-
diac lineage. Both young and old BM-MSCs expressed
the gap junction protein connexin-43. Therefore, it is
more probable that old BM-MSCs fused with NVCM
and took on their characteristics. Great interest in
BM-MSCs is based in part on their ability to improve
function, angiogenesis and neovascularivation via para-
crine and cytokine signaling; the same is to be
expected of transplanted young and old BM-MSCs.
The neovascularization and angiogenesis effects of
BM-MSCs are enhanced by the presence of specific
growth and cytokine factors [17,18,27]. In this study,
we observed markedly lower levels of G-CSF, IGF, EGF
and VEGF transcripts in old BM-MSCs.
The inability of old BM-MSCs to respond to differen-
tiation media maybe explained in part by the fact that
the BM-MSC isolation method typically results in slight
heterogeneity in the cell population at early primary iso-
lation due to hematopoietic stem cell contamination
which affects the in vitro behavior of the cells. We
observed higher contamination by hematopoietic stem
cells in old BM-MSC cultures at early passage by flow
cytometry (not shown). However, young and old BM-
MSCs uniformly expressed CD90, CD73 and CD105,
and failed to express CD45 and CD31 at passage 3. It is
more likely that the related genes necessary for efficient
adipogenesis, chondrogenesis, osteogenesis and cardio-
myogenesis were age-repressed in our old BM-MSCs
[27]. An Alternative explanation is that our old BM-
MSCs had already partially differentiated to another
lineage prior to induction with differentiation media.
This is highly unlikely; the differentiation experiments
in this study were carried out in triplicate (n = 3) on
individual cell populations derived from the bone mar-
row of individual rats (n = 4) for each age group. We
induced young and old BM-MSCs under uniform condi-
tions at passage 3.
The uniform expression of CD90, CD105, CD73 and
absence of CD31 and CD45 in either age group as
observed in this study indicates homogeneity in the BM-
MSC population. It does not necessarily correlate with
multidifferentiation capacity. Hence, the complete loss
of chondrogenic, osteogenic and cardiomyogenic poten-
tial may also be due to an age-related loss in multipo-
tency. The combinatorial transcription factor interaction
n e t w o r ko fO c t - 4 ,N A N O Ga n dS o x - 2w h i c hc o n f e r s
stemness and maintains pluripotency in embryonic stem
cells is well documented [25,32,33]. Using an in vitro
aging model, Yew et al. recently showed that BM-MSCs
show decreased expression of Oct-4 and NANOG at
late passage. They also showed that the knockdown of
p21 rescues the loss in differentiation capacity and
potentiates expression of Oct-4 and NANOG [7]. We
observed age-related changes in the expression profile of
the three pluripotency markers Oct-4, Sox-2 and
NANOG. Old BM-MSCs expressed Oct-4, albeit at a
lower intensity in comparison to young BM-MSCs, but
failed to express Sox-2 and NANOG. While its presence
does not automatically result in pluripotency, precise
levels of Oct-4 are required to maintain pluripotency in
embryonic stem cells, and its lack thereof results in
germ line specific differentiation [34,35].
Figure 5 Immunocytochemical analysis of Cardiomyogenic differentiation of BM-MSCs co-cultured with NVCM: Results of co-culture
with NVCM after 14 days. Representative micrographs of anti-GATA 4, Nkx2.5, connexin-43, cTnI, cTnT, MHC and a-sarcomeric actinin staining
in cultured BM-MSCs from each experimental group.
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Page 6 of 11Figure 6 Telomerase activity, growth and immunocytochemical assessment of DNA double strand break in young and old BM-MSCs:
(A) Representative micrographs of anti- g-H2AX staining in cultured BM-MSCs from each experimental group. (B) Columns show comparison of
telomerase activity between young and old BM-MSCs by qPCR. Cq values for young BM-MSCs are significantly lower indicating higher
enzymatically active telomerase. Data represent Mean ± SEM for three biologically independent experiments (n = 3). The ‘‡’ sign indicates a
significant difference between the indicated group and any passage 3 groups from older donors (p< 0.05). (C) Passage 0 BM-MSCs from
individual young and old rats were trypsinized, and enumerated with a Cedex HiRes non-flow imaging cytometer over 15 days.
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Taken together, our observations here present definitive
evidence that there are age-related changes in MSCs
d e r i v e df r o mt h eb o n em a r r o wo fo l dr o d e n t sw i t h
regard to plasticity and basic stem cell biology. These
results support the conclusion that the efficacy of BM-
MSCs is compromised as a function of donor age.
Methods
All experiments were performed in accordance with the
g u i d e l i n e so ft h eA n i m a lC a r ea n dU s eC o m m i t t e eo f
the Florida State University and with the Guide for the
Care and Use of Laboratory Animals (Department of
Health and Human Services, publication No. NIH 86-
23).
Experimental design
This study investigated among other factors the effect of
donor age on BM-MSC differentiation capacity into four
mesodermal lineages. BM-MSCs were isolated from four
individual “old” and “young” S p r a g u eD a w l e yr a t s( 1 5
months; 2 males and 2 females) and (4 months; 2 males
and 2 females), respectively. We did not pool bone mar-
row aspirates from the individual animals; all experi-
ments were performed on the separate cell lines isolated
from each individual animal. MSCs are currently being
used in several ongoing autologous clinical trials; hence
the objective of such a study design was to provide a
controlled analysis of the possible effect of individual
donor age on molecular predictors of BM-MSC efficacy.
Neonatal rats (age, 48 hrs, n = 12) were used for neona-
tal ventricular cardiomyocyte isolation.
Antibodies
FITC- or phycoerythrin (PE) coupled antibodies against
CD45 (559135; 1:100), CD31 (555027; 1:100), CD90
(554897; 1:100) and CD73 (551123; 1:100) were from
( B DP h a r m i n g e n ,S a nD i e g o ,C A ,U S A ) .M o u s eI g G 1 ,k
Isotype control (551954; 1:100) was from BD Pharmin-
gen. Secondary FITC conjugated anti-goat (705-075-003;
1:200), anti-rabbit (711-095-152; 1:200), and TRITC
conjugated anti-mouse (715-025-150; 1:200) antibodies
were from (Jackson Immunoresearch, West Grove, PA,
USA). Antibodies against CD105 (ab18278; 1:100), Ig2a
Isotype control (ab18449; 1:100), cardiac troponin-I
(ab19615-500; 1:100), cardiac Myosin Heavy Chain
(ab15-100; 1:100) and alpha Sarcomeric actinin (ab9465-
500; 1:100) were from (Abcam, Cambridge, MA, USA).
Antibodies against p-histone g-H2A.X (Ser-139) (sc-
101696.; 1:200), SOX-2 (sc-17320; 1:100), Oct-3/4 (sc-
9081; 1:100) and NANOG (sc-33760; 1:100) were from
(Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA).
Antibody against connexin-43 (71-0700; 1:100) was from
(Invitrogen, Carlsbad, CA, USA). Antibodies against
osteocalcin (MAB1419; 1:100), aggrecan (AF1220), and
FABP4 (AF1443; 1:100) were from (R&D Systems, Min-
neapolis, MN, USA).
Bone marrow stem cell isolation
BM-MSCs were isolated from the femur and tibia of
Sprague Dawley rats. Briefly, muscle and extra-ostial tis-
s u ew e r et r i m m e d .B o n em a r r o wp l u g sw e r ef l u s h e d
out, layered over 15 mL Ficoll solution (Sigma, St.
Louis, MO, USA) and centrifuged at 1500 rpm. The cell
layer at the interphase was aspirated, and washed with
PBS (Fisher, Pittsburgh, PA, USA) in 1% FBS (Innovative
Research, Novi, MI, USA). Bone marrow mononuclear
cells were transferred to culture flasks with Dulbecco’s
modified Eagle’sM e d i u m - h i g hg l u c o s e( [ D M E M - H G ]
(Sigma) supplemented with 20% FBS (Innovative
R e s e a r c h )a t3 7 ° Cw i t h5 %C O 2. After 3 days of culture,
the media and non-adherent cells were discarded and
fresh media added at 3-4 day intervals. Seed culture
cells were treated with 0.25% Trypsin-EDTA (Sigma) 7-
14 days after the initial plating and labeled as passage 1.
Neonatal heart cell isolation
Neonatal ventricular cardiomyocytes were isolated from
48 hours old Sprague Dawley rat litters (n = 12). Briefly,
neonatal rats were anesthetized with halothane, decapi-
tated, and hearts quickly removed and placed in 100
mm Petri dishes (Fisher) with cold phosphate-buffered
saline solution (PBS; KCl, 2.7 mmol/L; NaCl, 136.9
mmol/L; KH2PO4, 1.5 mmol/L; Na2HPO4, 8.1 mmol/L
[pH 7.3]). Hearts were minced into 1-mm
3 pieces,
washed with PBS and digested in 0.1% trypsin, 0.3% col-
lagenase and 0.5% DNAse (Worthington, Lakewood, NJ,
USA) for 5 minutes at 37°C. The cell suspension was
transferred into 30 mL of complete medium and centri-
fuged at 1500 rpm for 10 minutes. The cell pellet was
resuspended in complete medium (F-12 nutrient mix-
ture (Invitrogen) supplemented with 10% FBS and 10%
horse serum (Invitrogen), plated in 60 mm dishes
(Fisher) and cultured at 37°C in 5% CO2.
BM-MSC morphology, population size and flow cytometry
analysis
Primary isolation BM-MSCs derived from individual
young and old rats were compared prior to the first pas-
sage. BM-MSCs were evaluated under phase contrast
(BX61, Olympus; Tokyo, Japan) over 7 days beginning
at 24 hours post primary isolation. At passage 3, we
analyzed cells by flow cytometry; BM-MSCs from each
individual animal were grown to confluency, trypsinized,
and 1 × 10
6 cells were resuspended with phosphate-buf-
fered saline (PBS) in FACS tubes (BD Bioscience). Cells
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minutes on ice with the specific conjugated primary
antibody, and corresponding isotype control. The immu-
nostained cells were rinsed twice with cold PBS, and
analyzed on a FACScan (BD Bioscience). To compare
cell size and determine growth cycle, a Cedex HiRes
non-flow imaging cytometer was used to enumerate
BM-MSCs from each individual animal over 15
passages.
In vitro differentiation
We tested the multilineage differentiation capacity of
BM-MSCs by inducing differentiation into adipocytes,
osteoblasts, chondrocytes and cardiomyogenic cells
using the human stem cell functional identification kit
(R&D Systems) and a combination of growth factors,
according to the manufacturer’s protocol. We induced
adipogenesis, osteogenesis, chondrogensis and cardio-
myogenesis over 21 day’s culture in differentiation med-
ium containing (hydrocortisone, isobutylmethylxanthine
and indomethacin [R&D Systems]); (dexamethasone,
ascorbate-phosphate, and b-glycerolphosphate [R&D
Systems]); (dexamethasone, ascorbate-phosphate, pro-
line, pyruvate and TGF- b3 [R&D Systems]) and DMEM
(Sigma) supplemented with 5% FBS (Innovative
Research), 50 ng ml
-1 FGF-2 (R&D Systems), 5 ng ml
-1
IGF-1 (R&D Systems) and 20 ng ml
-1 of BMP-2 (R&D
Systems) respectively. Differentiation media was
refreshed every 3 days.
Co-culture system
Neonatal ventricular cardiomyocytes were cultured for
three days to subconfluency on glass cover slips placed
in 6-well tissue culture treated plates (BD Biosicience).
Third passage BM-MSCs were transduced overnight
with the BacMam 2.0 GFP transduction control (Invitro-
gen), trypsinized with 0.25% Trypsin EDTA (Invitrogen),
and layered over the subconfluent layer of ventricular
cardiomyocytes at a density of 1 × 10
6 MSCs per plate
to make up a co-culture system. The cells were incu-
bated at 37°C in 5% CO2. Cell fusion was determined by
dual expression of GFP (FITC) and cardiac specific pro-
teins (TRITC) by GFP positive BM-MSCs in close proxi-
mity to NVCMs (TRITC only).
Cell staining
Cells were fixed in 10% formaldehyde at room tempera-
ture for 5 minutes, and rinsed with isopropanol. Slides
were incubated with Oil-red-O (Fisher) for 20 minutes
at room temperature, and rinsed with distilled water.
For Alizarin Red staining of mineral deposits, cells were
fixed with 10% formaldehyde for 15 minutes, and rinsed
with distilled water. Slides were incubated with Alizarin
Red staining solution (Fisher) for 20 minutes at room
temperature, and rinsed with distilled water. BM-MSCs
were viewed under inverted phase-contrast microscope
(BX61, Olympus; Tokyo, Japan).
Immunofluorescence staining
For immunocytochemistry, cells were grown on glass
cover slips (Fisher) to subconfluency, washed with PBS,
fixed with 2% paraformaldehyde for 10 minutes at room
temperature, quenched with 100 mM Glycine (pH7) for
5 minutes, permeabilized with 0.1% Triton X-100 for 5
minutes, blocked with 1% BSA in PBS for 20 minutes at
room temperature, and sequentially incubated with
respective primary antibodies at 4°C overnight and then
with appropriate secondary antibodies for 1 hour at 37°
C. Between steps, PBS was used for washes and cells
were mounted with Prolong Gold Antifade with DAPI
(Invitrogen). Confocal images of immunostained cells
were obtained using a 40× oil objective on a Zeiss LSM
510 Laser Scanning Confocal Microscope (Zeiss, Frank-
furt, Germany). Digitized confocal images were pro-
cessed with Zeiss LSM Image Browser software, Rel. 4.2
and Adobe Photoshop.
Assessment of telomerase activity
Telomerase activities from young and old rat MSCs
were determined using the Quantitative Telomerase
Detection Kit (MT3010; Allied Biotech, Inc., German-
t o w n ,M D )a c c o r d i n gt ot h em a n u f a c t u r e r ’sp r o t o c o l .
Briefly, cell pellets were washed, resuspended in Lysis
Buffer and incubated for 30 minutes on ice. Protein
concentration was determined for each sample and
appropriate volumes of samples, heat inactivated
extracts and template controls were dispensed into indi-
vidual PCR tubes containing a pre-made master mix
supplied by the manufacturer. The Bio-Rad CFX96
Real-Time PCR Detection System (Bio-Rad, Hercules,
CA USA) was used to collect the appropriate Cq values
for each sample.
Real-time reverse transcription PCR (qRT-PCR)
Total RNA was extracted from rat BM-MSCs using Tri-
zol Reagent (Invitrogen) according to the manufacturer’s
protocol. For qPCR, 2 ug of total RNA was reverse tran-
scribed with the RT
2 First Strand Kit (Applied Biosys-
tems, Foster City, CA) according to the manufacturer’s
protocol. qPCR was performed using the SsoFast Eva-
Green supermix (Bio-Rad) according to the manufac-
turer’s instructions. The cycling profile for real-time
PCR (40 cycles) was as follows: 30 seconds at 95°C for
enzyme activation, 5 seconds at 95°C for initial dena-
turation, 5 seconds at 65°C for annealing/extension and
a5s e c o n dm e l tc u r v es t e pa t6 5 - 9 5 ° C .G e n ea n a l y s i s
was performed using the Bio-Rad CFX Manager soft-
ware (Bio-Rad). Gene expression is normalized relative
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http://www.biomedcentral.com/1471-2121/12/44
Page 9 of 11to unstimulated cells and fold variation is GAPDH nor-
malized. The primer sequences used have been shown
in Additional file 4.
Statistical Analysis
All differentiation and co-culture experiments were car-
r i e do u ti nt r i p l i c a t e( n=3 )p e ra n i m a li ne a c ha g e
group (n = 4). qPCR experiments represent three biolo-
gically independent experiments realized in duplicate.
Data are presented as mean ± SEM. Analyses of var-
iance (ANOVA) were performed using Sigma Plot soft-
ware from Systat Software, Inc (Chicago, IL, USA)
followed by Tukey’s multiple comparison tests to estab-
lish statistical significance between experimental groups
at the p < .05 (*) level.
Additional material
Additional file 1: MSC morphology and population size in young
and old bone marrow: (A) Representative phase-contrast
micrographs of resulting primary isolation BM-MSCs derived prior
to the first passage at 24 hours (24 h), 48 hours (48 h), day 5 and
day 7. (B) Passage 0 BM-MSCs from individual young and old rats were
trypsinized, and analyzed with a Cedex HiRes non-flow imaging
cytometer to determine the average cell diameter of each individual
MSC population. Representative phase-contrast micrographs from each
experimental group are shown.
Additional file 2: (A) Columns show fluorescence signal intensity
based on three independent differentiation experiments (n = 3) per
animal. The ‘‡’ sign indicates a significant difference between the
indicated group and any passage 3 groups from younger donors (p
<0.05). Error bars designate means ± SEM (n = 4).
Additional file 3: (A) VEGF, EGF, IGF and G-CSF expression
measured by qPCR. (B) Nkx2.5, GATA 4, cTnC, cTnI, cTnT and cTrpm
expression measured by qPCR following induction with growth factors
and conditioned media. Results are normalized for expression in
unstimulated cells at the same time of differentiation. Data represent
mean ± SEM of three biologically independent experiments realized in
duplicate. The ‘‡’ sign indicates a significant difference between the
indicated group and any passage 3 groups from younger donors (p
<0.05).
Additional file 4: Primer sequences for specific genes Additional
Statistical Analysis Fluorescence Signal Intensity Measurements.
Cardiomyogenic, osteogenic, chondrogenic and adipogenic
differentiation was carried out on each individual cell line from each
animal (n = 4, per group). Three independent differentiation experiments
(n = 3) were carried out for each cell line. Zeiss LSM Image Browser
software, Rel. 4.2 was used to determine percent fluorescence intensity.
Differences between groups following immunocytochemical evaluation
were compared by using 1-way ANOVA. Tukey’s multiple comparison
test was used to establish statistical significance between experimental
groups at the p < .05 (*) level. Negative controls for all
immunocytochemistry experiments represent secondary antibody
staining only.
List of Abbreviations
BM-MSC: bone marrow-derived mesenchymal stem cells; BMP-2: bone
morphogenetic protein 2; BSA: bovine serum albumin; cTnI: cardiac troponin
I; cTnT: cardiac troponins T; cTnC: cardiac troponin C: cTrpm: cardiac
tropomyosin; DAPI: 4’: 6-diamidino-2-phenylindole; DMEM-HG: Dulbecco’s
modified Eagle’s medium–high glucose; EGF: epidermal growth factor; FACS:
fluorescence-activated cell sorting; FBS: fetal bovine serum; FGF-2: fibroblast
growth factor 2; FITC: fluorescein isothiocyanate; G-CSF: granulocyte colony
stimulating factor; IGF-1: insulin-like growth factor 1; NVCM: neonatal
ventricular cardiomyocytes; OBM-MSC: old bone marrow mesenchymal stem
cells; PBS: phosphate buffered saline; PE: phocoerythrin; TRITC:
tetramethylrhodamine isothiocyanate; VEGF: vascular endothelial growth
factor; YBM-MSC: young bone marrow mesenchymal stem cells
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